Showing results (161-170 of 309) with videos related to
Sort By:
Pageof 31
Blood|August 1, 1992
Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemiaD F Claxton, C L Reading, L Nagarajan, et al.Cancer Genetics and Cytogenetics|September 1, 1983
Non-T, non-B acute lymphoblastic leukemia (L3) with t(8;22) and two 14q+ chromosomesR S Chaganti, S C Jhanwar, Z Arlin, et al.British Journal of Haematology|June 1, 1996
CD30 ligand is expressed on resting normal and malignant human B lymphocytesA Younes, U Consoli, S Zhao, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1978
RNA content in human lymphocyte subpopulationsM Andreeff, J D Beck, Z Darzynkiewicz, et al.Genes, Chromosomes & Cancer|March 1, 1994
Polysomy of chromosome 12 in 60 patients with non-Hodgkin's lymphoma assessed by fluorescence in situ hybridization: differences between follicular and diffuse large cell lymphomaA Younes, W Pugh, A Goodacre, et al.Leukemia|November 1, 1995
A pilot study of the biologic and therapeutic effects of granulocyte colony-stimulating factor (filgrastim) in patients with acute myelogenous leukemiaA Jakubowski, M Gordon, A Tafuri, et al.Blood|November 14, 1997
Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytesJ Chandra, J Gilbreath, E J Freireich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemiaP Benedetto, R Mertelsmann, T H Szatrowski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1995
PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cellsS Fu, U Consoli, E G Hanania, et al.Leukemia|February 17, 2006
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-CH Pelicano, J S Carew, T J McQueen, et al.Pageof 31